The ESG Weekly: Should investors care about antibiotic resistance? And only a handful of companies are preventing a deforestation‐free supply chain for the week of November 18..


Manage episode 246738756 series 2431150
By MSCI ESG Research LLC. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
Two stories this week with ESG glasses: Antibiotic resistance - the ability of germs to defeat the drugs designed to kill them - is one of the greatest public health challenges of our time; but as the crisis grows what will happen to the companies that produce antibiotics (0:54)? And then Mario Lopez-Alcala tells us which companies are slowing the transition to a deforestation free supply chain in South America (10:17), all through an ESG lens. Listen on Apple Podcasts.

62 episodes